Robert Banks's most recent trade in Nephros Inc was a trade of 50,000 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on May 14, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nephros Inc | Robert Banks | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 14 May 2024 | 50,000 | 70,000 (0%) | 0% | 2.2 | 112,050 | Common Stock |
| Nephros Inc | Robert Banks | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 10,406 | 10,406 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Robert Banks | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 07 Dec 2023 | 18,000 | 20,000 (0%) | 0% | 2.2 | 39,647 | Common Stock |
| Nephros Inc | Robert Banks | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 14 Aug 2023 | 1,901 | 2,000 (0%) | 0% | 1.7 | 3,207 | Common Stock |
| Nephros Inc | Robert Banks | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.51 per share. | 14 Aug 2023 | 99 | 99 (0%) | 0% | 1.5 | 149 | Common Stock |